Featuring the newest adherents to Plan S, how to make sure your data are re-useable and whether or not open access policies actually work.
Weekly digest: what’s happening in open science?
Featuring how libraries can support Plan S implementation, the Incentivization Blueprint encouraging funders to align with the principles of open research, and the effect on citation performance of a journal becoming open access.
Weekly digest: what’s happening in open science?
This Open Access Week 2018 special edition of the Open Pharma digest features an interactive dashboard of open access data, the cost of open access publishing for research funders, and the latest on Plan S.
Weekly digest: what’s happening in open science?
Featuring the Royal Society’s plan to combat the replication crisis, a new peer review tool for BMC journals, and the Open Pharma podcast!
Weekly digest: what’s happening in open science?
Featuring an interview with the architect of Plan S, the legal case being brought against ResearchGate, and a systematic review on the open access citation advantage.
Weekly digest: what’s happening in open science?
Featuring the open access citation advantage for research into poverty-related disease, Finland’s decision to join Plan S, and how ORCID can help the pharmaceutical industry.
Weekly digest: what’s happening in open science?
Featuring the FDA’s proposal to begin enforcing fines for research funders who don’t report their clinical trial results, the potential harms of over zealous ‘industry bashing’, and the barbecue joint for high impact authors.
Weekly digest: what’s happening in open science?
Featuring the story of open citations, the science of publishing, and the new open source peer-review platform.
Weekly digest: what’s happening in open science?
Featuring pharma taking the lead on sharing clinical trial results, where preprints end up, and the identity of peer reviewers.
Weekly digest: what’s happening in open science?
Featuring the ground-shaking new ‘Plan-S’ open access commitments, a critical look at the ‘moral high ground’ of academia, and open access: the movie.